Peripheral Blood Markers Associated with Immune-Related Adverse Effects in Patients Who Had Advanced Non-Small Cell Lung Cancer Treated with PD-1 Inhibitors

Peripheral Blood Markers Associated with Immune-Related Adverse Effects in Patients Who Had Advanced Non-Small Cell Lung Cancer Treated with PD-1 Inhibitors

Wenhui Liu,1,2 Yiping Liu,1,2 Fang Ma,3 Bao Sun,1,2 Ying Wang,1,2 Jianquan Luo,1,2 Mouze Liu,1,2 Zhiying Luo1,2 1Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, People’s Republic of China; 2Institute of Clinical Pharmacy, Central South University, C...

Full description

Bibliographic Details
Main Authors: Liu W, Liu Y, Ma F, Sun B, Wang Y, Luo J, Liu M, Luo Z
Format: Article
Language:English
Published: Dove Medical Press 2021-01-01
Series:Cancer Management and Research
Subjects:
immune check-point inhibitors
nsclc
irae
neutrophil-to-lymphocyte ratio
platelet-to-lymphocyte ratio
Online Access:https://www.dovepress.com/peripheral-blood-markers-associated-with-immune-related-adverse-effect-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/peripheral-blood-markers-associated-with-immune-related-adverse-effect-peer-reviewed-article-CMAR

Similar Items